Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company
Go back to Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 270.00 +7.83 (2.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $259.35 | 52 Week Low | $82.07 | |||
| Day High | $272.35 | P/E | 627.91 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 1,106,909 | |||||
